Physician profile
Matthew Kyle Brant
NPI 1356685572
$46,823.49
in general payments reported to CMS, 2019-2025
24 companies · $5,573 in 2025
The $5,573 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,064 · 2020: $3,508 · 2021: $5,466 · 2022: $9,799 · 2023: $5,590 · 2024: $9,824 · 2025: $5,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,790 · Consulting Fee: $6,129 · Food and Beverage: $4,469 · Travel and Lodging: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,789.60 |
| Consulting Fee | $6,129.30 |
| Food and Beverage | $4,469.39 |
| Travel and Lodging | $1,597.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $28,481.74 | 2020-2025 | Arthrex |
| Stryker Corporation | $4,537.41 | 2019-2025 | Citrefix, Augment Injectable, 7 X 23mm Citrelock Implant |
| Liberty Surgical INC. | $3,714.39 | 2019-2021 | |
| Synthes USA Products LLC | $2,320.00 | 2019 | |
| Wright Medical Technology, INC. | $1,249.87 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,197.60 | 2019 | |
| In2bones USA, LLC | $1,145.42 | 2019-2020 | |
| Smith+Nephew, INC. | $979.35 | 2019-2025 | Stravix Pl, Stravix Mesh, Grafix Pl |
| Treace Medical Concepts, INC. | $696.39 | 2022-2025 | |
| Eclipse Technology Solutions INC. | $637.61 | 2022-2025 | |
| Depuy Synthes Sales INC. | $408.85 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Zimmer Biomet Holdings, INC. | $403.35 | 2020-2022 | |
| Medshape, INC. | $318.62 | 2023-2025 | Dynanail, Dynanail Helix, Washer, 15 Mm, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Terumo Bct, INC. | $254.61 | 2019 | |
| Integra Lifesciences Corporation | $148.98 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $110.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Peter Brasseler Holdings, LLC | $37.22 | 2024 | |
| Medline Industries LP | $37.07 | 2023 | |
| Ethicon US, LLC | $33.45 | 2019-2025 | Stratafix |
| Axogen | $32.19 | 2019 | |
| Bioventus LLC | $24.83 | 2025 | Exogen Ultrasound Bone Healing System |
| Medtronic Vascular, INC. | $22.63 | 2019 | |
| Osiris Therapeutics INC. | $16.58 | 2019 | |
| Zyla Life Sciences, INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.